Real-World study tests ulcerative colitis drug etrasimod
NCT ID NCT06398626
First seen Jun 27, 2026 · Last updated Jul 10, 2026 · Updated 2 times
Summary
This study watches 300 adults with moderate to severe ulcerative colitis who are prescribed etrasimod by their doctor. Researchers track symptoms like stool frequency and rectal bleeding over 52 weeks using health questionnaires. The goal is to see how well the drug works outside of a controlled clinical setting.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLITIS, ULCERATIVE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
BI Research Center
RECRUITINGHouston, Texas, 77084, United States
-
Brooke Army Medical center
RECRUITINGSan Antonio, Texas, 78234, United States
-
Brooke Army Medical center
NOT_YET_RECRUITINGSan Antonio, Texas, 78234, United States
-
Digestive and Liver Center of Florida Kissimmee
RECRUITINGKissimmee, Florida, 34741, United States
-
Feinberg School of Medicine Northwestern University
RECRUITINGChicago, Illinois, 60611, United States
-
GI Alliance Research
RECRUITINGSouthlake, Texas, 76092, United States
-
Gastro Florida
TERMINATEDLutz, Florida, 33558, United States
-
Gastro Intestinal Research Institute of Northern Ohio, LLC
RECRUITINGWestlake, Ohio, 44145, United States
-
Houston Endoscopy & Research Center
RECRUITINGHouston, Texas, 77079, United States
-
Lenox Hill Hospital, Northwell Health
RECRUITINGNew York, New York, 10075, United States
-
MGG Group Co., Inc., Chevy Chase Clinical Research
RECRUITINGChevy Chase, Maryland, 20815, United States
-
Medical University of South Carolina (MUSC)
RECRUITINGCharleston, South Carolina, 29425, United States
-
NYU Langone Health
RECRUITINGNew York, New York, 10016, United States
-
OnSite Clinical Solutions, LLC
RECRUITINGCharlotte, North Carolina, 28211, United States
-
Orlando Health/Digestive Health Institute
NOT_YET_RECRUITINGOrlando, Florida, 32806, United States
-
Reddy GI Associates
RECRUITINGMesa, Arizona, 85206, United States
-
Rocky Mountain Gastroenterology
RECRUITINGLittleton, Colorado, 80120, United States
-
Rush University Medical Center
RECRUITINGChicago, Illinois, 60612, United States
-
Scripps Clinic Torrey Pines
RECRUITINGLa Jolla, California, 92037, United States
-
Suburban Gastroenterology Ltd
RECRUITINGNaperville, Illinois, 60540, United States
-
United Medical Doctors
RECRUITINGLos Alamitos, California, 90720, United States
-
United Medical Doctors
NOT_YET_RECRUITINGLos Alamitos, California, 90720, United States
-
University of Cincinnati College of Medicine
RECRUITINGCincinnati, Ohio, 45267, United States
-
University of North Carolina at Chapel Hill, Division of Gastroenterology and Hepatology
RECRUITINGChapel Hill, North Carolina, 27599, United States
-
Virtua Health
RECRUITINGMarlton, New Jersey, 08053, United States
-
WVU Medicine J.W Ruby Memorial Hospital
RECRUITINGMorgantown, West Virginia, 26505, United States
-
Washington Gastroenterology
RECRUITINGTacoma, Washington, 98405, United States
-
Woodholme Gastroenterology Associates PA
RECRUITINGGlen Burnie, Maryland, 21061, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new biologic tame ulcerative colitis?
- Can a Real-World study reveal the staying power of guselkumab?
- Can a new biologic calm the immune attack in ulcerative colitis?
- Can better detection of precancerous lesions in IBD prevent colorectal cancer?
- Dutch hospital data reveals hidden patterns in IBD treatment
- Kids' metabolism under the microscope: new study on IBD and energy burn